MOLECULAR INFORMATION
Molecular information
- Type
- Short peptide bioregulator · claimed bladder tissue modulator
Vesilute is one of the Khavinson family of “short bioregulator peptides”.
Claims vs evidence
- Bladder tissue support — preclinical only, single-group
- Overactive bladder benefit — claimed; no Western RCT
Why we grade it D
Same single-source evidence pattern as the rest of the family.
Frequently asked questions
- What is Vesilute?
- A short Khavinson-family bioregulator peptide marketed for bladder / urinary tract support, including overactive bladder and post-cystitis recovery claims.
- Is Vesilute authorised for urological use?
- No — not authorised by any major Western regulator.
- Why grade D?
- Same single-research-group evidence pattern as the rest of the Khavinson family.